Nanopharmaceuticals
Nanotechnology could be deliberately implemented in development of new drug delivery systems that can extend drug markets. Such a method would be applied to drugs selected for full-scale development based on their safety and efficacy information, but which fail to reach clinical development on account of poor bio pharmacological properties. The new drug delivery methods are required to enable pharmaceutical companies to reformulate existing drugs available, thereby expanding the lifetime of products and upgrading the performance of drugs by increasing effectiveness, safety and patient adherence, and finally lessening the healthcare costs.